Changing molecular epidemiology and characteristics of MRSA isolated from bloodstream infections: nationwide surveillance in Japan in 2019.
Norihito KakuDaisuke SasakiKenji OtaTaiga MiyazakiKatsunori YanagiharaPublished in: The Journal of antimicrobial chemotherapy (2022)
This study revealed that SCCmec type IV replaced SCCmec type II in MRSA BSIs. In addition, SCCmec type IV was divided into several types with different characteristics.